Unilab partners with TCS for cloud-led enterprise transformation
September 4, 2025Tata Consultancy Services (TCS) has announced a partnership with Unilab, a pharma company based in the Philippines, to modernise its …
Accro Bioscience and Fosun Pharma sign licence deal for autoimmune therapy in Greater China
September 4, 2025Accro Bioscience has granted Shanghai-based Fosun Pharma exclusive rights to develop, manufacture and commercialise its experimental therapy AC-201 in Greater …
Shaun Chilton appointed as hVIVO Non-Executive Chair
September 3, 2025hVIVO, a full-service Contract Research Organisation (CRO) involved in human challenge clinical trials has announced that Shaun Chilton has joined …
Vitalant and UPMC strengthen partnership in cell and gene therapy
September 3, 2025Vitalant, a blood and biotherapies provider, is expanding its collaboration with the University of Pittsburgh Medical Center (UPMC), Pennsylvania, US, …
Craig Rhodes appointed as Qureight Head of Partnerships
September 2, 2025Qureight, a techbio company, has appointed Craig Rhodes as Head of Partnerships to lead strategic engagements with pharmaceutical organisations. The …
VITROCELL system aims to improve drug and particle safety testing
September 2, 2025VITROCELL Systems has launched a new technology called Navetta to support researchers testing the safety of drugs and airborne particles …
FDA approves Moderna’s updated COVID-19 vaccines targeting new variant
September 1, 2025FDA
The US Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccines, Spikevax and mNEXSPIKE, intended to target the …
Lilly secures conditional MHRA approval for new blood cancer treatment
September 1, 2025The UK’s Medicines and Healthcare products Regulatory Agency has granted conditional marketing authorisation for Eli Lilly’s pirtobrutinib (Jaypirca). This new …
Rare and severe epilepsies – current treatments and advance therapeutics
August 29, 2025Medical Communications, Research and Development Neurology, UCB, epilepsy, epilepsy treatment, rare epilepsies
The current forms of immunotherapy, how T cell therapy works and what the future holds
Rotzinger launches modular filling and capping platform for over-the-counter products
August 29, 2025Manufacturing Services, Manufacturing and Production Devices, Rotzinger PharmaPack, manufacturing and production
Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle a wide range of over-the-counter …
Er-Kim to distribute CNX Therapeutics’ oncology drugs across Europe and Turkey
August 29, 2025Logistics & Distribution, Manufacturing and Production, Mergers and Acquisitions CNX Therapeutics, Corporate, Er-Kim, Oncology, central nervous system disorders, critical care
Turkish pharma company, Er-Kim, has signed a distribution agreement with CNX Therapeutics to expand access to a portfolio of oncology …
The Pharma Files: With Professor Hatim Abdulhussein from Health Innovation Kent Surrey Sussex
August 28, 2025Medical Communications, Research and Development Corporate, GP, Health Innovation Kent Surrey Sussex, The Pharma Files
Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …
How pharma marketing needs to adapt as community pharmacies take centre stage
August 28, 2025Business Services, Medical Communications, Sales and Marketing 10 Year Health Plan, Pharmacy, m3, pharmacy
The UK government’s 10-Year Health Plan is moving pharmacists to the frontline of primary care For decades, community pharmacies were …
European Commission approves HIV prevention injection
August 28, 2025Medical Communications, Research and Development European Commission, Gilead Science, HIV, HIV/AIDS, US Food and Drug Administration, World Health Organisation
The European Commission (EC) has granted marketing authorisation for Gilead Science’s Yeytuo (lenacapavir), the first twice-yearly injectable medicine approved in …
EMA grants orphan drug designation for Roca’s treatment of radiation maculopathy
August 28, 2025Medical Communications, Research and Development European Medicines Agency (EMA), Oncology, Opthalmology, Roca Therapeutics, maculopathy
The European Medicines Agency (EMA) has granted Orphan Drug Designation to Roca Therapeutics for its lead candidate RCT002, marking the …
The UK’s Life Sciences Sector Plan: a fresh launchpad or a continued labyrinth for the uptake of innovative medicines?
August 27, 2025Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health
As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …
Terumo to acquire Oxford spin-out OrganOx in $1.5b deal
August 26, 2025Mergers and Acquisitions Corporate, OrganOx, Terumo, University of Oxford, organ transplantation
Japanese medical technology company Terumo has announced it will acquire OrganOx, a University of Oxford, UK, spin-out specialising in organ …
Neogap Therapeutics appoints Jonas Mattson to its board of directors
August 26, 2025Research and Development Corporate, Immunology, Neogap Therapeutics, Oncology, board of directors
Swedish biotech, Neogap Therapeutics, has appointed Jonas Mattson, an authority in cell therapy, to its board of directors. His appointment …
FDA approves Wegovy for treatment of MASH in adults with liver fibrosis
August 22, 2025Medical Communications, Research and Development Hepatology, Novo Nordisk, US Food and Drug Administration, clinical trial, hepatitis, obesity
The US Food and Drug Administration (FDA) has granted accelerated approval for Wegovy (semaglutide) as a treatment for adults with …
Johnson & Johnson commits $2bn to new manufacturing facility in North Carolina, US
August 22, 2025Manufacturing and Production Corporate, Fujifilm, Johnson & Johnson
Johnson & Johnson has announced a $2bn investment in a new manufacturing facility in Holly Springs, North Carolina, US, expanding …
Latest content
FibroFind appoints Lee Borthwick as CEO
